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Etiology of Chronic Liver Disease in Children
M. Hanif, J. Raza, H. Qureshi*, Z. Issani
National Institute of Child Health and PMRC Research Centre*, Jinnah Postgraduate Medical Centre, Karachi.
Abstract
Objective: To review the clinical spectrum and  etiology of chronic liver disease in children at National Institute
of Child Health, Karachi.
Methods: Prospective study in children aged 1 to 14 years with suspected chronic liver disease. Complete blood
count, LFT's, prothrombin time, serum albumin and ultrasound of abdomen were done in all patients. Liver biopsy
was done in majority of the cases. Viral markers included HBsAg, anti HCV and ANA to determine etiology.
Those who were negative for hepatitis B, C and autoimmune disease, were subjected to slit lamp examination
of eyes and 24 hours urinary copper estimation for Wilson's disease. Alpha-1-antitrypsin levels were done in
selected patients. 
Results: A total of 55 cases were studied. The common presenting features were edema, ascites (44 patients),
jaundice (27), variceal bleeding (23) and fever (22). On examination anemia was present in 52 patients, edema
in 46, jaundice in 37, splenomegaly in 42 and hepatomegaly in 35 patients. Fortynine patients had
hypoalbuminemia (<2.5 gm%), 45 raised ALT (>80 IU/L) and 49 prolonged PT  (>4 sec of control).
Ultrasonography showed a dilated portal vein in 34 patients and esophageal varices were seen in 46 patients on
endoscopy. Thirteen (24%) had chronic hepatitis B, 9(16%) autoimmune disease, 9 (16%) Wilson's disease and
all were anti HCV negative. Etiology remained uncertain in 24 (44%) cases.
Conclusion: Hepatitis B was the leading cause of chronic liver disease in children followed by Wilson's disease
and autoimmune liver disease. None of the patients had hepatitis C in this study (JPMA 54:119;2004).
Introduction 
The common causes for chronic liver disease (CLD)
in children are hepatitis B, hepatitis C, hepatitis D,
autoimmune hepatitis and metabolic disorders like Wilson's
disease and a-1 antitrypsin deficiency. 1 In majority of the
patients the etiology remains uncertain.1-3 Literature from
West suggests that autoimmune hepatitis leads the list of
causes while infections are among the lowest; the biggest
chunk is however idiopathic.4,5 Few studies have looked at
the etiology of chronic liver disease in children in Pakistan
and one such study has reported hepatitis B as the leading
cause. 6 We undertook the present study to further define the
etiology of CLD in children.
Patients and Methods
All children aged 1 year to 14 years who were
admitted at National Institute of Child Health Karachi
(NICH) between February 1998 to December 1999 with
clinical stigmata of chronic liver disease were included in
the   study.  The  signs  of  chronic  liver  disease  included 
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deranged liver function tests (LFTs) for more than 3
months7, enlarged or shrunken liver, splenomegaly, edema,
ascites, bleeding from varices and cutaneous features like
spider angiomata/palmar erythema. A detailed history and
physical examination was done in all the cases and findings
recorded on a proforma. 
Children below 1 year and over 15 years having
chronic liver disease with malignancy, those with hemolytic
anemia and recurrent blood transfusions, patients with
storage disorders like glycogen and lipid storage disease
and those with congenital malformation of biliary tract like
congenital biliary atresia or choledochal cyst were
excluded.
Investigations included complete blood picture with
reticulocyte count, liver function test, prothrombin time,
serum albumin, ultrasound abdomen, hepatitis B surface
antigen (HBsAg), antibody to hepatitis C virus (anti HCV)
and antinuclear antigen (ANA). Slit lamp examination of
the eyes for Keyser-Fleischer (K.F.) rings were done in
patients negative for HBsAg, anti HCV and ANA. Children
with positive K.F. rings, underwent 24 hours urinary copper
estimation with and without D-Penicillamine challenge to
confirm Wilson's disease. Alpha-1-antitrypsin levels were
done in patients in whom no etiology was found. Liver
biopsy was done with Menghini`s needle or Tru-cut needle
in those cases where there was no contraindication and
where parental consent was obtained. Severity of chronic
liver disease was defined using Child's grading.3
Results 
A total of 55 children were included in the study. There
were 32 (58%) males and 23 (42%) females, whose ages
ranged from 3½ years to 14 years (Mean 8.28 years ± 2.75
SD). The common presenting symptoms were edema and
ascites in 44 (80%) patients followed by jaundice in 27 (49%)
patients. Bleeding from varices in the form of haematemesis
or malena or both was seen in 23 cases (42%) (Table 1). 
On examination anemia was seen in 52 (94%)
patients, jaundice in 37 (67%) and edema and ascites in 46
(84%) patients. Splenomegaly was found in 42 (76%),
hepatomegaly in 35 (64%). Other signs are shown in Table 1.
Out of 52 patients with anemia 14 (25%) were
severely anemic (hemoglobin less than 7 gm%) and 29
(53%) moderately anemic (hemoglobin level between 7-10
gm%). In the remaining children hemoglobin was more than
10 gm%. Serum bilirubin was between 1-3mg% in 33
(60%) patients, >3 mg% in 22 (40%) cases. In majority of
the patients bilirubin was conjugated. ALT was raised (>80
i.u/L) in 45 (82%). Hypoalbuminemia (serum albumin < 2.5
gm%) was seen in 49 (90%). Prothrombin time was
prolonged ( >4 seconds of control) in 49 (90%) patients.
(Table 2). According to Child's grade 49 (90%) patients
were in grade C, 6 (10%) in grade B and none in grade A.
Ultrasound of the abdomen showed a normal sized
liver in 16 (29%) cases, enlarged in 21 (38%) and shrunken
in 18 (33%) cases. Portal vein was dilated (more than 1
cms) in 34 (62%) cases. Upper GI Endoscopy was done in
50 (91%) cases, 46 (92%) patients had grade II esophageal
varices while 4 (8%) patients had no varices.
Liver biopsy was performed in 39 (71%) patients
and in 16 (29%) cases it could not be done due to child`s
condition or refusal by the parent. In 32 (82%) patients liver
biopsy revealed chronic active hepatitis while in 7 (18%)
cirrhotic changes. were reported.
HBsAg was positive in 13 (24%) patients and Wilson's
disease was the etiology in 9 (16%) patients. A positive ANA
indicating autoimmune hepatitis was found in 9 (16%) patients.
None of the patients were positive for Alpha-1-antitrypsin
deficiency or anti HCV. No etiology could be found in 24
(44%) patients, therefore they were labeled as idiopathic.
Table 1.  Clinical presentation.
Symptoms Signs
Edema/ascites 44 (80%) Anemia 52 (95%)
Jaundice 27 (49%) Jaundice 37 (67%)
Variceal bleed 23 (42%) Edema/ascites 46 (84%)
Fever 22 (40%) Splenomegaly 42 (76%)
Hepatomegaly 35 (64%)
Palmar erythema 02 (3.6%)
Spider haemangioma 02 (3.6%)
Table 2. Laboratory results.
LABS
Hemoglobin < 7 Gm% 14 (25%)> 7 Gm% 41 (75%)
Serum bilirubin 1-3 mg% 33 (60%)> 3 mg% 22 (40%)
SGPT > 80 i.u/L 45 (82%)
Serum albumin < 2.5Gm% 49 (90%)
PT > 4seconds of control 49 (90%)
Portal vein diameter > 1cm 34 (64%)
Endoscopy done in (n=50) Esophageal varices seen in 46pts (92%)
Liver biopsy done in (n=39) CAH     32 (82%)Cirrhosis 7 (18%)
CAH = Chronic active hepatitis.
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Discussion
This study shows that chronic liver disease (CLD) is
not a major disease in children. Slight male predominance
(58%) seen in this study is similar to that reported both
locally and internationally.8-10 A higher mean age of 8.2
years was seen in our study, while it was 4.5 years in
another local study9 and 6.1 years in a study done abroad.6
Edema and ascites were the major presenting
symptoms in the present study, being 80% as opposed to
30% reported from Lahore6 and 50% reported in another
study from Karachi.9 (Table 3) This high incidence of
edema and ascites in our study indicates fairly advanced
disease with decompensation. Incidence of jaundice,
bleeding varices, fever, hepatosplenomegaly, spider nevi
and palmar erythema in the present study was similar to that
reported in other studies from Pakistan6,9 and  India.10
Anemia was seen in 94% cases in this study, which
is similar to what has been reported earlier. 9 This high
incidence of anemia in CLD may be due to a number of
factors like, GIT bleed due to varices, sequestration of blood
in enlarged spleen, increased red cells vulnerability to
osmotic haemolysis, oxidant injury to R.B.C. due to vitamin
E and glutathione deficiency. Anemia can also be
immunologically mediated due to antibodies, injury to RBC
by toxic material like excessive copper and due to
nutritional deficiencies like iron, vitamin B12 and folic
acid.11
In chronic liver disease serum bilirubin, serum
albumin and prothrombin time are the markers of
progression of the liver disease. Rising bilirubin and
prothrombin time and lowering of albumin are bad
prognostic signs. In the present study hyperbilirubinemia
(>1mg%) was seen in 75% cases, which is slightly lower
than 90% reported in two other local studies.6,9 Serum
albumin was low (<2.5gm%) in 89% cases and, prolonged
prothrombin time (>2 times of normal) in 65%. Similar
results were reported by others.6 Transaminase levels
(SGPT/ALT) are not a marker for advanced liver disease
because they return to baseline once decompensation sets
in; they are useful only in assessing the chronic liver disease
where they are raised. In the present study ALT was raised
(>1½ times of normal) in 82% cases which is higher than
70% and 42% reported in other studies.6,9
Ultrasound is a useful imaging technique, which can
provide essential information in all forms of chronic liver
disease. In our study ultrasonographic hepatomegaly was
seen in 31% cases and it was shrunken in 33%, signifying
that in CLD one may have an enlarged to a fibrosed liver
depending upon severity and chronicity of underlying
disorder. Ultrasonographic splenomegaly was seen in 80%
cases and portal vein was dilated in 62% cases, denoting
portal hypertension.
In the present study endoscopic examination of
upper GIT was performed in 50 patients, and it revealed
esophageal varices in 46 patients (92%) a sign of portal
hypertension. Only 42% cases had history of haematemesis,
indicating that patients with CLD have esophageal varices
without history of upper GIT bleed. These varices are a
potential site of bleeding and an early endoscopic
examination can identify these high-risk children who can
be controlled by prophylactic ß blockers. 
Percutaneous liver biopsy is an excellent
investigation to evaluate the exact pattern and extent of liver
disease. In our series liver biopsy was performed in 71%
cases whereas in other studies it was performed in 60% and
45% cases respectively.6,9 On histology 32 (82%) cases had
chronic active hepatitis (CAH) and  7 (18%) had cirrhotic
changes; when compared to another local study, CAH was
reported in 55.5% and cirrhosis in 39% cases6 indicating
that there were more chronic and cirrhotic cases in the
previous study.
In this study HBV infection was the commonest
etiological factor causing CLD in 13 patients (24%), as
compared to 18% in a local study from Karachi9, 47% from
Lahore6 and 80% from Italy.8 Vertical or horizontal
transmission of the HBsAg is probably the cause of high
antigenemia in our study. A high HBsAg carrier rate of 10%
in general population12-14 and 15% HBe antigen positivity
in mothers also indicates a high chance of transmission of
the disease to the new borns.5 It is therefore recommended
Table 3. Comparison of clinical presentation.
Symptoms No.  (%) No.  (%) No.  (%)
Present study Malik8 Mehnaz9
n = 55 n = 30 n = 80
Edema 44 (80%) 9 (30%) 59 (75%)
Abd. Distension 44 (80%) 9 (30%) 59 (75%)
Jaundice 27 (49%) 22 (73%) 40 (50%)
Variceal bleed 23 (42%) 4 (13%) 12 (15%)
Fever 22 (40%) 15 (50%) 53 (67%)
Signs
Anemia 52 (95%) 17 (56%) 60 (75%)
Jaundice 37 (67%) 22 (73%) 40 (50%)
Edema/ascites 46 (84%) 9 (30%) 50 (62%)
Splenomegaly 42 (76%) 19 (63%) 40 (50%)
Hepatomegaly 35 (64%) 20 (66%) 44 (55%)
Palmar erythema 02 (3.6%) Not mentioned 2 (2.5%)
Spider haemangioma 02 (3.6%) Not mentioned 2 (2.5%)
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by WHO that all pregnant females should be screened for
HBsAg and HBeAg . The newborns of those found positive
for 'e' antigen, should  be vaccinated with. hepatitis B hyper
immunoglobulin 0.50ml within 12 hours of birth along with
1st dose of hepatitis B vaccine at a different sites.11 The over
all incidence of HBV infection can be reduced by
vaccination against hepatitis B on mass level, imparting
health education, limiting the use of blood transfusion, use
of screened blood and blood products and use of disposable
syringes. Reuse of needles and syringes should be
discouraged at all levels.         
In none of our patients hepatitis C was found as
causative agent for CLD. Local as well as international
literature also has not shown hepatitis C as etiology of CLD
in children6,8,9 reflecting that although hepatitis C is one of
the major cause of CLD in adults, its prevalence is not that
high in pediatric age group.   
In 9 patients (16%) of the present study, the cause of
CLD was identified as Wilson's disease. Similar results
were reported in another local study.6 But in an Italian
study8 of 196 patients of CLD was identified as Wilson's
disease in only 3 patients (1.53%). The high incidence of
Wilson's disease in our study is alarming, as this disorder is
not commonly reported in local literature as a cause of CLD
and has probably remained under diagnosed. It is
recommended that the entity should always be anticipated
and evaluated in children with CLD. This not only has the
beneficial effect on the patient, but can also identify
asymptomatic carriers in family.
Another autosomal recessive disorder that may
cause CLD is a-1-antitrypsin deficiency but it was not found
in our study. Bortolotti8 had reported 1 patient, reflecting
that a-1 antitrypsin deficiency is a rare cause of CLD in
children. There is no specific treatment for this disorder
except liver transplantation.15
In our study autoimmune hepatitis was established
as etiology for CLD in 9 patients (16%), whereas in other
local study9 it was seen in one patient only (1.2%)
autoimmune hepatitis is a common cause of CLD in the
West16 but in our country this disorder is reported very
infrequently, either because this entity is undetermined or
serological tests to confirm this disorder are expensive. 
Twenty patients (44%) in our study remained
idiopathic because we were unable to establish the etiology
of CLD as compared to 26.7% in a local and 4.9% in an
Italian study.6,8 This high frequency of idiopathic CLD in
our study reflects our financial constrains as well as non-
availability of advanced and specific diagnostic tools to find
out other underlying causes of CLD. The frequency of
idiopathic CLD also varies in different parts of world. In
United Kingdom it is about 5-10%, whereas other areas
such as France and urban parts of United States of America
where alcoholism is prevalent, the proportion of idiopathic
CLD is lower. As specific diagnostic facilities appear, the
percentage of idiopathic CLD falls, like advent of HBsAg
and anti HCV transferred many previously designated
idiopathic CLD to post-hepatitis group.3 Still there remains
significant percentage of patients with CLD as idiopathic
and etiological diagnosis in these patients awaits further
development of specific diagnostic tools.
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